Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117384) titled 'The role of serum lipid metabolism indexes in the progression of diabetic nephropathy' on Jan. 23.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Affiliated Hospital of Southwest Medical University
Condition:
Diabetic kidney disease ( DKD )
Intervention:
The diabetes nephropathy group (DKD) with high levels of PCSK9 and angptl3:None
Type 2 diabetes mellitus without concurrent diabetic nephropathy group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: The diabetes nephropathy group (DKD) with high levels of PCS...